NICE has cleared the way for bevacizumab to be used by the NHS to treat colorectal cancer for the first time, thanks to the availability of lower-cost biosimilar versions of the drug. In recently ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback